1,322 results match your criteria: "Cardiac Rhabdomyoma"

[Arrhythmia as the first symptom of neonatal cardiac tumors: Case report].

Rev Med Inst Mex Seguro Soc

November 2024

Instituto Mexicano del Seguro Social, Hospital General Regional No. 17, Servicio de Cardiología Pediátrica. Cancún, Quintana Roo, México.

Article Synopsis
View Article and Find Full Text PDF
Article Synopsis
  • Primary cardiac tumors (PCTs) like myxomas and lipomas are rare, with lipomas being soft fat masses that can lead to diagnostic challenges.
  • Lipomatous hypertrophy of the atrial septum (LHAS) is a benign condition linked to aging and obesity, distinct from true cardiac lipomas.
  • A case of a true atrial septal lipoma discovered during heart dissection is detailed, highlighting its potential effects on heart function and contributing to the scarce literature on benign primary cardiac tumors.
View Article and Find Full Text PDF
Article Synopsis
  • * The study involved a literature review of existing research on the use of mTOR inhibitors for managing TSC during pregnancy, focusing on case reports and studies of pregnant women and prenatal mouse models.
  • * Preliminary findings suggest that mTOR inhibitors could effectively reduce cardiac rhabdomyomas, but more research is necessary to understand their potential in preventing neurological issues while ensuring safety for fetal development.
View Article and Find Full Text PDF

Birt-Hogg-Dubé syndrome (BHDS) is a rare autosomal disorder, primarily characterised in adults by cutaneous features, pulmonary cysts that predispose to spontaneous pneumothorax and renal tumours. The syndrome is caused by pathogenic variants in the tumour suppressor gene, which plays a role in the mammalian target of rapamycin (mTOR) signalling pathway. We present the case of a newborn infant diagnosed with BHDS, who died of sudden cardiac death due to complications from cardiac rhabdomyoma.

View Article and Find Full Text PDF

Cardiac rhabdomyoma is the most common primary cardiac tumor in infants and can be diagnosed by fetal echocardiography. This benign tumor can be found in various locations within the heart, including the left ventricle, right ventricle, or septum, and is typically multiple. While spontaneous regression may occur, hemodynamic disorders, arrhythmias, and sudden death have also been reported.

View Article and Find Full Text PDF

Third Trimester Stillbirth Associated With Hamartoma of Mature Cardiac Myocytes (HMCM).

Pediatr Dev Pathol

September 2024

BCNatal | Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), University of Barcelona, Barcelona, Spain.

Article Synopsis
  • * The stillborn was 32 weeks gestation, and an autopsy revealed a structurally normal heart with a small nodule beneath the membranous septum.
  • * The nodule, consisting of disorganized cardiac cells and mild fibrosis, was identified as a rare tumor called HMCM, highlighting the need to consider it in diagnosing fetal heart tumors.
View Article and Find Full Text PDF

Type and dimensions can predict ventricular arrhythmias and cardiac death in primary benign cardiac tumors in children.

Int J Cardiol

January 2025

Pediatric Cardiology and Cardiac Arrhythmias and Syncope Unit, Bambino Gesù Children's Hospital, IRCSS, 00146 Rome, Italy; European Reference Network for Low Prevalence and Rare Disease of the Heart- ERN Guard Heart, Italy. Electronic address:

Article Synopsis
  • Primary benign cardiac tumors in children are rare but can lead to serious complications like malignant ventricular arrhythmias and cardiac death.
  • A study conducted over 38 years included 97 children with various types of tumors, revealing that those with tumors larger than 2.3 cm or diagnosed with fibromas had worse health outcomes.
  • The research highlighted that 24.5% of the patients experienced clinically significant arrhythmias, suggesting that tumor type and size are important indicators of potential risks.
View Article and Find Full Text PDF

Echocardiography-Guided Radiofrequency Ablation for Cardiac Tumors.

JACC CardioOncol

August 2024

Xijing Ultrasound Interventional Treatment Center for Cancer, Department of Ultrasound, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.

Article Synopsis
  • Patients with cardiac tumors often face difficulties with surgery due to their poor health, and a new procedure called TARFACT offers a less invasive way to provide palliative care.
  • The study involved five patients with various types of cardiac tumors who underwent TARFACT, followed by comprehensive assessments through different medical tests.
  • Results showed significant reductions in tumor size, improved heart function, and better overall health in most patients over a follow-up period, indicating TARFACT’s potential as a viable treatment option.
View Article and Find Full Text PDF

Characteristics and Outcomes of Fetal Cardiac Rhabdomyoma With or Without mTOR Inhibitors, a Systematic Review and Meta-Analysis.

Prenat Diagn

September 2024

Maternal Fetal Care Center, Division of Fetal Medicine and Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Article Synopsis
  • The study aimed to analyze the features and outcomes of fetal cardiac rhabdomyoma, comparing cases with and without prenatal treatment using mTOR inhibitors (mTORi).
  • A review of 61 studies identified 400 fetuses, revealing various complications such as arrhythmias and effusions, with a notable 12% fetal demise rate; 60% of cases were also linked to tuberous sclerosis.
  • The findings indicated that fetuses treated with mTORi showed improvements in tumor size and reduced complications, with no cases of fetal demise or neonatal death among the treated group.
View Article and Find Full Text PDF
Article Synopsis
  • A 22-year-old male with a history of tuberous sclerosis presented with chest pain and was found to have cardiac rhabdomyomas through echocardiography.
  • Late-onset cardiac rhabdomyomas in adults are rare but possible, highlighting the need for regular checkups for those with tuberous sclerosis complex. *
View Article and Find Full Text PDF

Case Report: Patent ductus arteriosus with tuberous sclerosis complex.

Front Cardiovasc Med

July 2024

Department of ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

Article Synopsis
  • A 33-year-old patient with a long-standing patent ductus arteriosus (PDA) was examined, revealing various fibromas and a shagreen patch, leading to a genetic test that confirmed Tuberous Sclerosis Type 2 (TSC2).
  • The patient underwent additional imaging studies, which validated the presence of PDA, a condition more commonly associated with TSC in children rather than adults.
  • The article aims to investigate the genetic relationship between TSC and PDA through a review of existing literature.
View Article and Find Full Text PDF

Genotypic and phenotypic analysis of Korean patients with tuberous sclerosis complex.

Neurogenetics

October 2024

Division of Pediatric Neurology, Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.

Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder caused by mutations in the TSC1 or TSC2 gene. The aim of this study was to analyze the genotypes and phenotypes of Korean patients diagnosed with TSC and expand our understanding of this disorder. This retrospective observational study included 331 patients clinically diagnosed with TSC between November 1990 and April 2023 at Severance Children's Hospital, Seoul, South Korea.

View Article and Find Full Text PDF

Arrhythmia as a Presenting Feature of Atypical Cardiac Rhabdomyoma in Children.

CJC Pediatr Congenit Heart Dis

June 2024

Department of Cardiac Sciences and Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the use of Cardiac Magnetic Resonance (CMR) parametric mapping to better characterize pediatric cardiac tumors, an area that hasn't been thoroughly explored.
  • In a sample of 16 pediatric patients, various tumors were identified, including hemangiomas, fibromas, rhabdomyomas, and lipomas, with significant differences found in native T1 and extracellular volume (ECV) values among these types.
  • The findings suggest that mass mapping analysis is both feasible and reliable for children, with ECV values being particularly useful for differentiating tumor types, closely resembling normal heart tissue in rhabdomyoma, and showing distinct measurements in the other tumor types.*
View Article and Find Full Text PDF
Article Synopsis
  • - Sudden infant death syndrome (SIDS) is a common but poorly understood cause of mortality in infants, with pediatric cardiac tumors possibly contributing to some cases.
  • - Autopsies, including both gross and microscopic heart examinations, are vital to identifying hidden cardiac tumors like rhabdomyomas, which can lead to sudden death.
  • - A case of a healthy 5-month-old infant appeared to be SIDS at first, but microscopic analysis revealed a cardiac rhabdomyoma that was missed during gross examination, highlighting the need for thorough microscopic analysis to avoid missed diagnoses.
View Article and Find Full Text PDF